New therapies for systemic lupus erythematosus — past imperfect, future tense
New therapies for systemic lupus erythematosus — past imperfect, future tense
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The failure of many new, mostly biologic, drugs to meet their primary end points in double-blind clinical trials in patients with systemic lupus erythematosus (SLE) has caused a profound sense of disappointment among both physicians and patients. Arguably, the success of B cell depletion with rituximab in open-label studies and in patients with lup...
Alternative Titles
Full title
New therapies for systemic lupus erythematosus — past imperfect, future tense
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2252276708
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2252276708
Other Identifiers
ISSN
1759-4790
E-ISSN
1759-4804
DOI
10.1038/s41584-019-0235-5
